advertisement
Tsang SH 38
Showing records 1 to 25 | Display all abstracts from Tsang SH98430 Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors
Nolan ND
Eye 2022; 36: 278-283
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Cui X
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Wu WH
Molecular Therapy 2022; 30: 1407-1420
97975 A mutation in causing pigmented paravenous retinochoroidal atrophy
Oh JK
European Journal of Ophthalmology 2022; 32: NP235-NP239
98430 Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors
Caruso SM
Eye 2022; 36: 278-283
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Kim HJ
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Tsai YT
Molecular Therapy 2022; 30: 1407-1420
97975 A mutation in causing pigmented paravenous retinochoroidal atrophy
Nuzbrokh Y
European Journal of Ophthalmology 2022; 32: NP235-NP239
98430 Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors
Caruso SM
Eye 2022; 36: 278-283
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Huang IW
Molecular Therapy 2022; 30: 1407-1420
97975 A mutation in causing pigmented paravenous retinochoroidal atrophy
Lee W
European Journal of Ophthalmology 2022; 32: NP235-NP239
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Cheng CH
Human Molecular Genetics 2022; 31: 2438-2451
98430 Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors
Cui X
Eye 2022; 36: 278-283
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Huang IW
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Jenny LA
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Cheng CH
Molecular Therapy 2022; 30: 1407-1420
98430 Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors
Tsang SH
Eye 2022; 36: 278-283
97975 A mutation in causing pigmented paravenous retinochoroidal atrophy
Lima de Carvalho JR; Wang NK
European Journal of Ophthalmology 2022; 32: NP235-NP239
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Hsu CW
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
De Carvalho Junior JRL
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Cui X
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Chang YJ
Human Molecular Genetics 2022; 31: 2438-2451
97975 A mutation in causing pigmented paravenous retinochoroidal atrophy
Sparrow JR
European Journal of Ophthalmology 2022; 32: NP235-NP239
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Kong Y
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Ryu J
Molecular Therapy 2022; 30: 1407-1420
